Skip to main content
NIH funding notice RFA-AG-23-032

Network for Personalization of Diagnostic Tests for Alzheimers Disease (AD) and Alzheimers Disease-Related Dementias (ADRD) in Older Adults with Multiple Chronic Conditions (MCCs) (U24 Clinical Trial Optional)

Closed on October 17, 2022.

Posted
June 14, 2022
Close date
October 17, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,884,695 in first-year total cost, median $1,884,695.

Most frequent study sections

  1. Special Emphasis Panel[ZAG1 ZIJ-R (M2)]1

Most frequent institutions

  1. WAKE FOREST UNIVERSITY HEALTH SCIENCES1
Competing awards under RFA-AG-23-032 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023Alzheimer Diagnosis in older Adults with Chronic Conditions ADACC Network1U24AG082930-01FOWLER, NICOLE R.KARIKARI, THOMAS KMIELKE, MICHELLE MWILLIAMSON, JEFF DOUGLASWAKE FOREST UNIVERSITY HEALTH SCIENCES, NC$1,884,695ZAG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-AG-23-032: Network for Personalization of Diagnostic Tests for Alzheimers Disease (AD) and Alzheimers Disease-Related Dementias (ADRD) in Older Adults with Multiple Chronic Conditions (MCCs) (U24 Clinical Trial Optional) | ScienceDex | ConductScience